Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000031

Chief Scientific Officer sold 18,980 shares at an average $15.16 ($287,695)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2024-05-16 Sale 10b5-1 −1,000 $15.00 $15,000 208,032 D
Sethuraman Natarajan Chief Scientific Officer 2024-05-17 Sale 10b5-1 −8,305 $15.14 $125,751 199,727 D
Sethuraman Natarajan Chief Scientific Officer 2024-05-20 Sale 10b5-1 −9,675 $15.19 $146,944 190,052 D
Open-market sales · 18,980 sh · avg $15.16 · $287,695
Loading xslF345X05/wk-form4_1716240336.xml…